Citadel Advisors’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6K | Buy |
+17,187
| New | +$12.6K | ﹤0.01% | 5670 |
|
|
2025
Q1 | – | Sell |
-144,769
| Closed | -$1.53M | – | 6629 |
|
|
2024
Q4 | $1.53M | Buy |
144,769
+144,699
| +206,713% | +$1.53M | ﹤0.01% | 2867 |
|
|
2024
Q3 | $925 | Sell |
70
-860,373
| -100% | -$11.4M | ﹤0.01% | 5626 |
|
|
2024
Q2 | $8.46M | Sell |
860,443
-963,540
| -53% | -$9.47M | ﹤0.01% | 1315 |
|
|
2024
Q1 | $25.1M | Sell |
1,823,983
-19,308
| -1% | -$265K | ﹤0.01% | 789 |
|
|
2023
Q4 | $30.3M | Sell |
1,843,291
-325,227
| -15% | -$5.35M | 0.01% | 668 |
|
|
2023
Q3 | $29.7M | Buy |
+2,168,518
| New | +$29.7M | 0.01% | 633 |
|